NCT00213109已完成3 期
Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 7
研究概览
简要总结
The purpose of this study is evaluate the clinical efficacy and safety of Miglitol in patients with Type1 Diabetes Mellitus treated with insulin.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type1 Diabetes
- •Criteria of postprandial glucose and HbA1c are met
排除标准
- •Type2 Diabetes
- •Patients with antidiabetic drugs
- •The other exclusion criteria are met
研究者
研究点 (7)
Loading locations...
相似试验
已完成
3 期
Open Trial of Miglitol in Type 2 Diabetic Patients Treated With BiguanideType 2 Diabetes MellitusNCT00334503Sanwa Kagaku Kenkyusho Co., Ltd.
已完成
3 期
Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With BiguanideType 2 Diabetes MellitusNCT00334399Sanwa Kagaku Kenkyusho Co., Ltd.
已完成
3 期
Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin TreatmentType 2 Diabetes MellitusNCT00213070Sanwa Kagaku Kenkyusho Co., Ltd.
已完成
1 期
Treatment of Type I Diabetes by Islet Transplantation Into the Gastric Submucosa Study ProtocolDiabetes Mellitus, Type 1NCT02402439Chuck Rickert, MD, PhD1
进行中（未招募）
1 期
A Study of DM001 in Patients With Advanced Solid TumorsSolid CarcinomaCarcinoma, Non-Small-Cell LungBreast NeoplasmsNCT06475937Xadcera Biopharmaceutical (Suzhou) Co., Ltd.128